<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(6)</volume><submitter>Verstovsek S</submitter><funding>NCI NIH HHS</funding><journal>Leukemia</journal><pagination>1413-5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4895165</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis.</pubmed_title><pmcid>PMC4895165</pmcid><funding_grant_id>P30 CA016672</funding_grant_id><pubmed_authors>Mesa R</pubmed_authors><pubmed_authors>Gupta V</pubmed_authors><pubmed_authors>Atallah E</pubmed_authors><pubmed_authors>Verstovsek S</pubmed_authors><pubmed_authors>Mascarenhas J</pubmed_authors><pubmed_authors>Montgomery M</pubmed_authors><pubmed_authors>Sun H</pubmed_authors><pubmed_authors>Gotlib J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2025-04-20T01:55:50.654Z</modification><creation>2025-04-20T01:55:50.654Z</creation></dates><accession>S-EPMC4895165</accession><cross_references><pubmed>26526986</pubmed><doi>10.1038/leu.2015.310</doi></cross_references></HashMap>